menu
    • menu

    Company profile for PRM Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PRM is a privately held specialty pharmaceutical company focused on developing lower-dose medications. With roots dating to the 1990s, our team pioneered Microzide (12.5 mg HCTZ), a widely prescribed antihypertensive. We leverage decades of R&D experience to create precise, patient-friendly formulations in areas like CNS, cardio-metabolic, and allergy. Partnering with global manufacturers, we deliver therapies that balance eff...
    PRM is a privately held specialty pharmaceutical company focused on developing lower-dose medications. With roots dating to the 1990s, our team pioneered Microzide (12.5 mg HCTZ), a widely prescribed antihypertensive. We leverage decades of R&D experience to create precise, patient-friendly formulations in areas like CNS, cardio-metabolic, and allergy. Partnering with global manufacturers, we deliver therapies that balance efficacy and safety through optimized dosing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PRM PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Barr Harbor Drive, Suite 400, West Conshohocken, PA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://prmpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PRM Pharma Launches Hemiclor 12.5 mg Nationwide For Hypertension
    PRM Pharma Launches Hemiclor 12.5 mg Nationwide For Hypertension

    07 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/prm-pharma-announces-nationwide-availability-of-hemiclor-chlorthalidone-12-5-mg-the-first-fda-approved-low-dose-chlorthalidone-tablet-aligned-with-hypertension-guidelines-302607317.html

    PR NEWSWIRE
    07 Nov 2025
    Share Share
    Low-Dose Hemiclor Now Available in Pharmacies
    Low-Dose Hemiclor Now Available in Pharmacies

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/a-new-chapter-in-the-story-of-chlorthalidone-low-dose-hemiclor-now-available-in-pharmacies-nationwide-302488541.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    FDA Approves Low-Dose HemiClor For Hypertension
    FDA Approves Low-Dose HemiClor For Hypertension

    06 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-new-low-dose-chlorthalidone-for-the-treatment-of-hypertension-in-adults-hemiclor-12-5-mg-chlorthalidone-302446420.html

    PR NEWSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search